I am trying out the Burge lab's MISO program for isoform analysis. I want to use the mm9 file posted on their website, but within the mm9 folder are many subfolders with different pickled GFF annotations, I can't seem to get MISO to like any of these files. Which files do I feed MISO? Anyone else have this trouble, or have better experience using their own indexed alternative events file? Anyone gotten MISO to work?
-
-
Yh, I have tried their hg18 GFF annotations for alternative splicing analysis, it works well. -
Miso
good to hear it is working for you - did you run it using the TandemUTR or A3SS/A5SS indexes? for the input file I navigate to the mm9_alt_events/home/yarden/sugarman/gff-events/mm9/pickled/TandemUTR folder -within that folder are the .shelve file and the individual chromosome folders containing pickle files. Trying to run from this folder gives me errors. What do I use as my input file? test_miso.py gives me an OK. Do I need to prepare the pickled files?
thanks, any help is appreciated.Comment
-
I tried all the events including TandemUTR and A3SS/A5SS indexes, I think you can use their scripts and gff files to generate the pickled files ,not the final annotation files they already provided.Comment
-
MISO - got it thanks
Thanks, I got it working now.Comment
-
Miso vs. cufflinks
For miso users: What is the feature that distinguish miso from cufflinks, and helped you take miso as your favorite tool?Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment